focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allotment of Adviser Shares

13 Sep 2010 07:00

RNS Number : 5329S
Ipso Ventures PLC
13 September 2010
 



13 September 2010

IPSO Ventures plc

("IPSO" or the "Company")

 

Allotment of Adviser Shares

 

The Board of IPSO announced on 27 August 2010 that approval had been granted at a general meeting for, inter alia, the increase of the Company's share authorities for the allotment of securities to satisfy the second tranche of the Subscription (being the Second Subscription) to raise £325,000. The Company has now received notification of the subscription details for the remaining 250,000 Adviser Shares and has therefore allotted these shares.

 

Application has been made for the 250,000 Adviser Shares to be admitted to trading on AIM ("Admission") and it is anticipated that Admission will take place on or around 16 September 2010. Following Admission there will be 16,439,210 ordinary shares in issue in IPSO. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, IPSO under the FSA's Disclosure and Transparency Rules.

 

The 250,000 Adviser Shares are being issued to Arka Technologies Limited ("Arka"), a company 100% owned by Craig Rochford, Non-Executive Director of IPSO. Following Admission Craig Rochford will have an interest in 383,333 ordinary shares in IPSO, equivalent to 2.33 per cent. of the enlarged issued share capital of the Company.

 

Following Admission it is the intention of Arka to sell 200,000 Adviser Shares to a third party at the subscription price, in order to enable it to pay certain costs on behalf or the investors.

 

All defined terms used in this announcement have the meaning given to them in the circular sent to shareholders of the Company on 4 August 2010 (the "Circular") unless otherwise defined herein.

For further information, please contact:

 

IPSO Ventures plc

Simon Hunt, Executive Chairman

Nick Rodgers, Chief Executive Officer

 

Tel: 020 7921 2990

simon@ipsoventures.com

nick@ipsoventures.com

www.ipsoventures.com

 

Allenby Capital Limited

Nick Naylor

Nick Athanas

 

Tel: 020 3328 5656

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISLLFSRASIILII
Date   Source Headline
5th Aug 20107:00 amRNSNotice of General Meeting
30th Jul 20107:00 amRNSPreliminary Results 2010
27th Jul 20103:15 pmRNSIssue of Equity
12th Jul 20107:00 amRNSChange of Adviser
25th Jun 20107:00 amRNSTHERAKIND SALE OF INTEREST IN PRODUCT
22nd Jun 20107:00 amRNSIPSO SIGNS COLLABORATION AGREEMENT WITH B1 MEDICAL
12th May 20107:00 amRNSMedermica Files Second Technology Patent
30th Apr 20107:00 amRNSTotal Voting Rights
1st Apr 20109:28 amRNSIssue of New Shares
9th Mar 20107:00 amRNSAXILICA WINS SUBSTANTIAL GRANT
15th Feb 20107:00 amRNSPolyfect enters due diligence agreement
29th Jan 20107:00 amRNSInterim Management Report 2009
14th Jan 20107:00 amRNSIPSol Energy first customer revenues
30th Nov 20097:00 amRNSTotal Voting Rights
6th Nov 200912:19 pmRNSIssue of Shares
6th Nov 200911:39 amRNSDirector's Interest in Shares and Share Options
5th Nov 200910:02 amRNSDirector/PDMR Shareholding
4th Nov 20097:00 amRNSIpso Creates Photovoltaic Testing Business
19th Oct 20097:00 amRNSpH Technology - Development Agreement Signed
15th Oct 20097:00 amRNSTherakind Product Update
11th Sep 20098:42 amRNSResult of AGM
24th Jul 20097:00 amRNSPreliminary Results 2009
8th May 20097:00 amRNSMedermica Files Technology Patent
3rd Apr 20097:00 amRNSSuccessful Fundraising for Therakind
27th Feb 20092:54 pmRNSDirector/PDMR Shareholding
19th Jan 20097:00 amRNSInterim Results
17th Dec 20087:00 amRNSChange of Registered Office
18th Nov 20081:16 pmRNSIssue of New Shares
17th Nov 20084:00 pmRNSAppointment of Joint Broker
4th Nov 20087:00 amRNSAcquisition of Cambridge Meditech
30th Sep 20087:00 amRNSAxilica Limited Update
25th Jul 20087:00 amRNSFinal Results
10th Jul 20087:00 amRNSInvestment in Polyfect Soluti
10th Jan 20087:01 amRNSInterim Results
24th Oct 20072:23 pmRNSAnnual Report and Accounts
25th Sep 20077:00 amRNSInvestment in Axilica
10th Sep 20074:10 pmRNSAdditional Listing
20th Aug 20077:02 amRNSRe: AIM Rule 26
25th Jul 20077:00 amRNSFinal Results
17th Jul 200711:47 amRNSDirector/PDMR Shareholding
5th Jul 20077:01 amRNSFurther investment in IWC
15th Jun 20077:00 amRNSTherakind Investment Update
1st Jun 20077:01 amRNSTotal Voting Rights
23rd May 20072:00 pmRNSIssue of Equity
30th Mar 20075:04 pmRNSTotal Voting Rights
21st Mar 200710:45 amRNSHolding(s) in Company
8th Mar 200711:52 amRNSIssue of Equity
7th Mar 20078:05 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.